Synaptophysin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Synaptophysin |
|---|
| Protein Name | Synaptophysin |
| Gene | SYP |
| UniProt ID | P08247 |
| Protein Length | 313 amino acids |
| Molecular Weight | ~38 kDa |
| Subcellular Location | Synaptic vesicle membrane |
| Protein Family | Synaptophysin family |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Epilepsy, Schizophrenia |
Synaptophysin (encoded by the SYP gene) is the most abundant integral membrane protein of synaptic vesicles, constituting approximately 6-8% of total synaptic vesicle protein content. As a founding member of the synaptophysin family, this protein serves as the gold standard marker for synaptic density and has been extensively utilized in neuropathology studies of neurodegenerative diseases[1]. Its universal presence in virtually all synaptic terminals makes it invaluable for assessing synaptic integrity in conditions ranging from Alzheimer's disease to epilepsy[2].
- Length: 313 amino acids
- Molecular weight: Approximately 38 kDa
- Transmembrane domains: 4 hydrophobic regions
- N-terminus: Cytoplasmic, contains phosphorylation sites
- Transmembrane regions: Four transmembrane helices
- C-terminus: Cytoplasmic, interacts with synaptic proteins
- Forms hexameric or heptameric channels
- Creates a pore-like structure in synaptic vesicle membrane
- Can form homo-oligomers
- Phosphorylation: Multiple serine residues (PKA, CaMKII sites)
- Glycosylation: N-linked glycosylation in extracellular loops
- Palmitoylation: Acyl chain modifications for membrane association
As the major synaptic vesicle protein, synaptophysin participates in:
- Critical for synaptic vesicle formation
- Involved in vesicle maturation
- Organizes vesicle protein composition
- Modulates synaptic vesicle recycling
- Regulates endocytosis and exocytosis
- Controls vesicle pool dynamics
- Synaptobrevin-2/VAMP2: Direct interaction in SNARE complex
- Syntaxin-1: Partner in synaptic fusion machinery
- SNAP-25: Completes the SNARE complex
- Synaptotagmin-1: Calcium sensor for release
- Coordinates fusion machinery with calcium influx
- CSPα/DNAJC5: Chaperone for synaptic proteins
- Hsc70: Heat shock protein involvement
- AP-2: Clathrin adaptor in endocytosis
Synaptophysin is essential for normal synaptic function:
- Vesicle organization: Maintains synaptic vesicle pools
- Release modulation: Regulates neurotransmitter release probability
- Plasticity: Contributes to short-term and long-term plasticity
- Homeostasis: Adapts to changing neural activity
- Universal presynaptic marker across all brain regions
- Highest density in: cerebral cortex, hippocampus, cerebellum
- Expressed in both excitatory and inhibitory neurons
Synaptophysin loss is a hallmark of AD:
- Hippocampus: 30-50% reduction in AD vs. controls
- Cortex: 20-40% reduction correlating with cognitive decline
- Entorhinal cortex: Earliest synaptic loss in prodromal AD
Correlations:
- Cognitive scores: MMSE, CDR correlations
- Amyloid burden: Inverse correlation with plaque load
- Tau pathology: Correlates with neurofibrillary tangles
- Disease progression: MCI → AD transition marker[3]
In PD and Lewy body diseases:
- Loss of cortical synaptophysin in PD with dementia
- Correlation with cognitive impairment severity
- Early marker of terminal dysfunction
- Dopaminergic terminal vulnerability
- Altered expression in epileptic foci
- Marker of excitatory/inhibitory imbalance
- Surgical target identification
- Reduced synaptophysin in prefrontal cortex
- Evidence for synaptic pathology
- Correlates with cognitive deficits
- Measures synaptic degeneration
- Monitors disease progression
- Treatment response biomarker
- PET ligands for synaptic density (SV2A as proxy)
- Correlates with cognitive function
- SYP promoter-driven therapeutic expression
- Viral vector approaches
- Preserve synaptic terminals
- Enhance synaptic function
- Prevent synaptic loss
- Biomarker validation: CSF synaptophysin clinical utility
- Imaging: PET synaptic density ligands
- Mechanism: Precise role in vesicle cycling
- Therapy: Gene and cell-based approaches
- Models: Transgenic and knockout studies
- SYP knockout: Viable, subtle synaptic deficits
- SYP overexpression: Enhanced plasticity and memory
- AD models: Correlation with amyloid pathology
The study of Synaptophysin Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Wiedenmann B, Franke WW. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell. 1985;41(3):1017-1028.
[2] Masliah E, Terry RD, DeTeresa R, Hansen LA. Immunohistochemical quantification of the synaptic marker synaptophysin in Alzheimer disease. Neurosci Lett. 1989;103(2):234-239.
[3] Counts SE, Mufson EJ. Synaptophysin. In: Kreutz MR, Sala C, eds. Synaptic Plasticases. Springer; 2012:145-158.